左金丸水提取液提高ATG4B含量促进自噬抑制三阴性乳腺癌进展
Zuojinwan Suppressing Triple Negative Breast Cancer Progression by Promoting ATG4B and Inducing Autophagy
-
摘要: 为研究中药左金丸水提取液对乳腺癌进展的影响, 选用正常乳腺上皮细胞(MCF10A)、乳腺癌细胞(MCF7)、三阴性乳腺癌细胞(MB231)进行体外细胞实验研究。通过肿瘤细胞表型分析, 证实左金丸对三阴性乳腺癌发展有显著抑制作用, 可显著抑制其增殖能力、迁移能力、侵袭能力及克隆形成能力。同时, 其对正常乳腺细胞无显著性影响。进一步通过蛋白筛选分析, 发现左金丸可显著性提高MB231 ATG4B蛋白水平, 并显著性促进细胞自噬进程。通过药物诱导体外实验, 确认了激活自噬进程可显著抑制MB231的肿瘤表型。此外, 采用CRISPR/Cas9技术建立ATG4B敲除的MB231细胞株, 将左金丸水提取液暴露该模型细胞后, 发现左金丸对三阴性乳腺癌的抑制作用及对胞内自噬的调控能力均显著性减弱。结果表明: ATG4B蛋白是左金丸在三阴性乳腺癌MB231中的高特异性靶点, 左金丸水提取液可显著提高ATG4B的表达, 进而促进细胞自噬进程, 抑制三阴性乳腺癌进展。Abstract: Zuojinwan is a traditional Chinese medicine, and the important role of water extract of Zuojinwan in breast cancer progression was shown. Zuojinwan significantly inhibited cell proliferation, migration and invasion in triple-negative breast cancer (TNBC) cells, however, it had no significant effect on normal breast epithelial cells. Additionally, the effect of Zuojinwan on TNBC may involve inducing cell autophagy by upregulation of ATG4B. Moreover, autophagy induction suppressed TNBC progression. The knockout of ATG4B abolished the Zuojinwan induced autophagy and significantly reduced the inhibitory effect of Zuojinwan on TNBC, which suggests that ATG4B is essential for the Zuojinwan-induced autophagy in the TNBC cells. Therefore, Zuojinwan has a significant anti-cancer effect on TNBC by inducing ATG4B-mediated autophagy, which may provide a potential strategy for the treatment of TNBC.